Brokerages Set Sotera Health Company (NASDAQ:SHC) Price Target at $16.00

Shares of Sotera Health Company (NASDAQ:SHC) have received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $16.00.

Several equities research analysts have issued reports on SHC shares. Barclays reissued an “overweight” rating on shares of Sotera Health in a report on Friday, August 8th. Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 16th.

Sotera Health Trading Down 0.3%

Shares of Sotera Health stock opened at $16.25 on Monday. The firm has a market capitalization of $4.62 billion, a PE ratio of 203.15 and a beta of 1.84. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. The company’s fifty day moving average price is $14.06 and its two-hundred day moving average price is $12.50. Sotera Health has a 52-week low of $9.53 and a 52-week high of $16.99.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.03. The firm had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, analysts expect that Sotera Health will post 0.61 EPS for the current year.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the business’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the sale, the director owned 41,215,301 shares in the company, valued at approximately $622,763,198.11. The trade was a 16.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Pincus & Co. Warburg sold 12,000,000 shares of the business’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the completion of the sale, the director owned 61,822,952 shares in the company, valued at $934,144,804.72. This represents a 16.26% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 20,126,611 shares of company stock worth $304,273,888. Corporate insiders own 47.55% of the company’s stock.

Institutional Investors Weigh In On Sotera Health

Several institutional investors and hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its position in Sotera Health by 33.1% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 3,583 shares of the company’s stock worth $40,000 after buying an additional 892 shares in the last quarter. Teacher Retirement System of Texas lifted its position in Sotera Health by 4.1% during the 2nd quarter. Teacher Retirement System of Texas now owns 23,707 shares of the company’s stock worth $264,000 after buying an additional 933 shares in the last quarter. Principal Financial Group Inc. lifted its position in Sotera Health by 0.3% during the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock worth $4,109,000 after buying an additional 1,037 shares in the last quarter. Optimize Financial Inc lifted its position in Sotera Health by 7.7% during the 1st quarter. Optimize Financial Inc now owns 14,545 shares of the company’s stock worth $170,000 after buying an additional 1,041 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its position in Sotera Health by 1.9% during the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company’s stock worth $691,000 after buying an additional 1,100 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.